S. Nickel et al. / Bioorg. Med. Chem. 20 (2012) 601–606
605
(m, 4H), 3.65 (m, 8H), 3.55 (t, 2H, J = 5.4 Hz), 3.25 (t, 2H, J = 7.0 Hz),
0.88 (s, 9H), 0.05 (s, 6H); 13C NMR (CDCl3): d 72.8, 72.1, 70.9, 70.8,
70.4, 26.1, 18.5, 3.1, ꢁ5.1; TLC (cyclohexane/ethyl acetate 5:1):
Rf = 0.35; ESI-MS: tR 4.31 min, m/z 419.20 [M+H]+, 419.11 calcd
for C14H33IO4Si+.
69.6, 65.2, 64.4, 61.9, 30.9, 27.8, 16.6; TLC (CHCl3/methanol
19:1): Rf = 0.30; LC–MS (ESI): tR 7.19 min, m/z 396.00 [M+H]+,
396.18 calcd for C16H31NO8P+.
4.2.7. Synthesis of 2-(2-(2-(2-(chloro)ethoxy)phosphory)ethoxy)
ethoxy)ethoxy)ethyl prop-2-yn-1-yl carbamate (11)
4.2.3. Synthesis of diethyl(2,2,3,3-tetramethyl-4,7,10,13-
tetraoxa-3-silapentadecan-15-yl-phosphonate (7)
To a solution of 10 (80 mg, 0.2 mmol) in DCM (1 mL) was added
dropwise oxalyl chloride (0.34 ml, 4.0 mmol, 20 equiv) and the
resulting mixture was stirred over night at room temperature.
The solvent was removed under a stream of argon and dried under
high vacuum. The remaining residue 11 (76.4 mg, 0.19 mmol, 99%)
was used in the next step without any further purification. 1H NMR
(CDCl3): d4.51–4.45 (m, 3H), 4.42–4.18 (m, 3H), 3.89–3.75 (m, 4H),
3.69–3.61 (m, 8H), 2.53 (dt, 2H, J = 18.1, 7.4 Hz), 2.32 (t, 1H,
J = 2.4 Hz), 1.39 (t, 3H, J = 7.1 Hz); 13C NMR (CDCl3): d 152.1, 76.4,
73.0, 70.8, 70.7, 70.6, 68.4, 68.1, 64.6, 35.4, 33.2, 16.1; 31P NMR
(CDCl3): d 40.6.
Compound
6 (5.5 g, 13.1 mmol) was dissolved in P(OEt)3
(12.4 mL, 71 mmol, 5.4 equiv) and heated up to 150 °C and stirred
for 1 h at this temperature. The excess of P(OEt)3 was subsequently
removed in high vacuum and the residue purified on silica gel col-
umn (DCM/methanol 50:1), yielding 5.1 g (12 mmol, 91%) of the
desired product 7. 1H NMR (CDCl3): d 4.14–4.03 (m, 4H), 3.73 (m,
4H), 3.65–3.58 (m, 8H), 3.54 (t, 2H, J = 5.4 Hz), 2.16–2.07 (m, 2H),
1.30 (t, 6H, J = 7.1 Hz), 0.88 (s, 9H), 0.05 (s, 6H); 13C NMR (CDCl3):
d 72.8, 70.9, 70.6, 70.3, 65.3, 62.8, 61.8, 27.8, 26.4, 26.1, 16.6, ꢁ5.1;
31P NMR (CDCl3): d 29.6; TLC (DCM/methanol 50:1): Rf = 0.20;
ESI-MS: tR 4.32 min, m/z 429.20 [M+H]+, 429.25 calcd for
4.2.8. Synthesis of 2-(2-(2-(2-(ethoxy(4-nitrophenoxy)
phosphoryl)ethoxy)ethoxy)ethoxy)ethyl prop-2-yn-1-yl
carbamate (12)
C
18H42O7PSi+.
4.2.4. Synthesis of diethyl(2-(2-(2-(2-hydroxyethoxy)ethoxy)
ethoxy)ethyl)phosphonate (8)
To a solution of 11 (76.4 mg, 0.19 mmol) in toluene (1 mL) was
added dropwise
a
solution of para-nitrophenol (55.6 mg,
A solution of 7 (5.1 g, 12.0 mmol) in THF (150 mL) was cooled to
0 °C and TBAF (13.1 mL of a 1 M solution in THF, 14.0 mmol,
1.25 equiv) was added slowly. The resulting mixture was stirred
over night and warmed to room temperature. The reaction was
quenched by addition of water and the resulting mixture was ex-
tracted three times with DCM. Drying of the organic phase over so-
dium sulfate and purification by silica gel chromatography (DCM/
methanol 19:1) led to 2.8 g (8.8 mmol, 73%) of the desired product
7. 1H NMR (CDCl3): d 4.13–4.03 (m, 4H), 3.75–3.57 (m, 14 H), 2.12
(dt, 2H, J = 18.8, 7.6 Hz), 1.30 (t, 6H, J = 7.1 Hz); 13C NMR (CDCl3): d
72.7, 70.7, 70.5, 70.2, 65.3, 61.8, 27.7, 26.4, 16.6; TLC (DCM/MeOH
19:1): Rf = 0.40; ESI-MS: tR 4.31 min, m/z 315.13 [M+H]+, 315.16
calcd for C12H28O7P+.
0.38 mmol, 2 equiv) and triethylamine (0.14 mL, 0.95 mmol,
5 equiv) in toluene (1 mL). The resulting mixture was stirred for
3 h at room temperature and then evaporated to dryness. The sub-
sequent purification by silica gel column chromatography (CHCl3/
methanol 50:1) yielded 38.7 mg (0.08 mmol, 40%) of the desired
product 12. 1H NMR (CDCl3): d 8.23 (d, 2H, J = 9.2 Hz), 7.39 (d,
2H, J = 9.2 Hz), 4.30–4.14 (m, 4H), 3.96 (d, 2H, J = 2.5 Hz), 3.87–
3.77 (m, 2H), 3.69–3.65 (m, 2H), 3.61 (d, 8H, J = 6.5 Hz), 2.33
(dt, 2H, J = 18.6, 7.1 Hz), 2.22 (t, 1H, J = 2.4 Hz), 1.32 (t, 3H,
J = 7.1 Hz); 13C NMR (CDCl3): d 155.7, 155.3, 144.7, 125.8, 121.3,
78.9, 71.6, 70.7, 70.5, 69.6, 64.8, 64.4, 63.4, 30.9, 28.2, 16.5;
31P NMR (CDCl3): d 28.0; TLC (CHCl3/methanol 50:1): Rf = 0.06;
LC–MS (ESI): tR 8.58 min, m/z 489.00 [M+H]+, 489.17 calcd for
C
20H30N2O10P+.
4.2.5. Synthesis of 2-(2-(2-(2-(diethoxyphosphoryl)ethoxy)
ethoxy)ethoxy)ethyl(2,5-dioxopyrrolidin-1-yl)carbonate (9)
Compound 8 (2.0 g, 6.4 mmol) was dissolved in DMF (18.7 mL,
0.34 M) and N,N0-disuccinimidyl carbonate (3.6 g, 14.1 mmol,
2.2 equiv) and NEt3 (2.2 mL, 16.0 mmol, 2.5 equiv) were added.
The resulting mixture was stirred over night at room temperature.
Water and DCM were added and the organic and water phase were
separated. The organic layer was washed three times with brine,
separated and the organic phase was dried over sodium sulfate.
After silica gel chromatography (DCM/methanol 50:1), 1.44 g
(3.2 mmol, 49%) of the desired product 9 was obtained. 1H NMR
(CDCl3): d 4.45–4.42 (m, 2H), 4.12–4.03 (m, 4H), 3.79–3.57 (m,
12H), 2.82 (s, 4H), 2.11 (dt, 2H, J = 18.7, 7.6 Hz), 1.29 (t, 6H,
J = 7.1 Hz); 13C NMR (CDCl3): d 168.7, 151.7, 71.0, 70.7, 70.3, 68.4,
65.2, 61.8, 27.7, 25.6, 16.6; TLC (DCM/methanol 50:1): Rf = 0.20;
ESI-MS: tR 4.21 min, m/z 456.20 [M+H]+, 455.16 calcd for
4.2.9. Synthesis of TriNP (3)
To a solution of 12 (0.4 mg, 0.9
water (0.3 mL) was added TCEP (3
l
l
mol) and 13 (1 mg, 0.9
L of a 50 mM solution in water,
L of a 100 mM solution in DMSO,
mol, 0.5 equiv) and CuSO4 (30 L of a 5 mM solution in water,
lmol, 0.25 equiv). The resulting mixture was stirred in the
lmol) in
0.15 lmol, 0.25 equiv), TBTA (3 l
0.3
l
l
0.15
dark over night at room temperature. The mixture was evaporated
to dryness and the crude residue was purified by C18 reversed
phase silica gel (water with 20% CH3CN–50% CH3CN) to yield
0.4 mg (0.26 mmol, 28%) of the desired product 3. TLC (CH3CN/
water 1:1): Rf = 0.45; LC–MS (ESI): tR 7.48 min, m/z 1567.60
[M+H]+, 1589.53 [M+Na]+, 784.80 [M+2H]2+, 1567.71 calcd for
C
75H104N14O19PS+.
4.3. Profiling and target identification
C
17H31NO11P+.
4.3.1. Sample preparation
4.2.6. Synthesis of 2-(2-(2-(2-(diethoxyphophoryl)ethoxy)
ethoxy) ethoxy)ethyl prop-2-yn-1-yl carbamate (10)
Arabidopsis thaliana leaf extracts were obtained by grinding 2 g
of frozen leaves of 4-week-old A. thaliana ecotype Col-0 in a mortar
at room temperature (22–24 °C) to a homogenous green paste. The
paste was mixed with 5–6 mL of distilled water and cleared by
centrifugation (5 min at 16,000ꢀg). The protein concentration
was determined by using the Reducing agent Compatible/Deter-
gent Compatible (RC/DC) Protein Assay (Bio-Rad) following the
manufacturer’s instructions.
To a solution of 9 (405.5 mg, 0.89 mmol) in methanol (5 mL)
were added propargylamine (73.5 mg, 1.3 mmol, 1.5 equiv) and so-
dium bicarbonate and the resulting mixture was stirred over night
at room temperature. The solvent was evaporated and purification
on silica gel column (CHCl3/methanol 19:1) yielded 281.1 mg
(0.71 mmol, 80%) of the desired product 10. 1H NMR (CDCl3): d
4.26–4.21 (m, 2H), 4.14–4.04 (m, 4H), 3.95 (s, 2H), 3.76–3.59 (m,
12H), 2.22 (t, 1H, J = 2.3 Hz), 2.12 (dt, 2H, J = 18.7, 7.5 Hz), 1.31 (t,
6H, J = 7.1 Hz); 13C NMR (CDCl3): d 162.7, 79.9, 71.5, 70.7, 70.3,
Full-length CXE12 (At3g48690) cDNA was amplified from an A.
thaliana cDNA library (kindly provided by Dr. Hans Sommer, Max
Planck Institute for Plant Breeding Research) using the primers